Learn, Analyse & Invest
only with
only with
+91
Download Orca
Raaj Medisafe India Ltd.
Raaj Medisafe India
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Small-cap - With a market cap of ₹1.20 Cr.
| EX-Date | Purpose |
|---|---|
| 21 06 2021 | Audited Results |
| 12 08 2021 | Quarterly Results & A.G.M. |
| 12 11 2021 | Quarterly Results |
| 14 02 2022 | Quarterly Results |
| 25 05 2022 | Audited Results |
| 09 08 2022 | Quarterly Results |
| 11 11 2022 | Quarterly Results |
| 08 02 2023 | Quarterly Results |
| 13 02 2023 | Quarterly Results (Revised) |
| 29 05 2023 | Audited Results |
| 08 08 2023 | Quarterly Results & A.G.M. |
| 08 11 2023 | Quarterly Results |
| 16 01 2024 | To consider and approve expansion of existing manufacturing capacities of the Company as per letter attached. |
| 09 02 2024 | Quarterly Results |
| 29 02 2024 | Increase in Authorised Capital & Preferential Issue of shares |
| 12 11 2024 | Quarterly Results |
| 11 02 2025 | Quarterly Results |
| 29 03 2025 | Inter-alia, to consider and approve sale of Building and shed situated at Plot No. 75/4, Industrial Area, Maksi Road, Ujjain-456010. |
| 27 05 2025 | Audited Results(Cancelled) (Cancelled) |
| 29 05 2025 | Audited Results |
| 21 07 2025 | Inter-alia to consider and approve the forfeiture of 63300 partly paid up equity shares of Rs. 10 each (Paid up to the extent of Rs. 5.00 per share). |
| 11 08 2025 | Quarterly Results |
| 12 11 2025 | Quarterly Results |
| 23 12 2025 | Preferential Issue of shares & Increase in Authorised Capital Inter alia to transact following businesses: - 1. To take note of Minutes of previous Board and committee meetings. 2. To consider and approve the expansion and/or diversification of the Company?s existing manufacturing capacities for packing materials and hygiene products, including the purchase of plant and machinery and acquisition of business on a going-concern basis, and to authorise the person(s) for the same. 3. To consider and to approve raising of funds upto Rs. 1800 Lakhs through issuance of eligible securities of the company by way of private offerings including, preferential allotment and/or private placement and/or such other means. b. Consent u/s 62 of the Companies Act, 2013 to issue and allot eligible securities of the Company upto aggregate value of Rs. 1800.00 Lakhs (including premium) on Private Placement /Preferential Basis to Select Group of persons who are Non-Promoters. Any other item may be taken up for consideration with the permission of Chairman and with the consent of majority of directors present in the meeting which shall include at least one Independent Director of the company 4. To consider and to convene Extra-ordinary General Meeting of the Company on Tuesday, the 20th day of January, 2026 through VC/OAVM. 5. To consider and to approve appointment of CDSL to provide remote and e-voting facility during EoGM and to provide facility for conducting the EoGM through VC/OAVM. 6. To consider and to appoint Scrutinizer to scrutinize the evoting (remote) and EGM. 7. To consider and approve Notice convening Extra-ordinary General Meeting which inter-alia contains the items of Special Business: a. Increase in Authorised Capital from Rs. 1500.00 Lakhs to Rs. 1800 Lakhs |
| 11 02 2026 | Quarterly Results |
| 26 03 2026 | Preferential Issue of shares |
News
No News data available
